scholarly journals 97: Optimizing oral glucose tolerance test completion at a pediatric cystic fibrosis care center: A 10-year continuing quality improvement effort

2021 ◽  
Vol 20 ◽  
pp. S49
Author(s):  
P. Capel ◽  
M. Fischer ◽  
E. Meier ◽  
J. Haynes ◽  
C. Oermann ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Quality Improvement ◽  
Glucose Tolerance Test ◽  
Care Center ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance ◽  
Quality Improvement Effort ◽  
Test Completion ◽  
Improvement Effort

scholarly journals 220: Using lean methodologies to influence oral glucose tolerance test completion in cystic fibrosis patients

2021 ◽  
Vol 20 ◽  
pp. S107-S108
Author(s):  
S. Lavin ◽  
B. Paul ◽  
E. Giezendanner ◽  
J. Garbarz ◽  
C. Stradley ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Glucose Tolerance ◽  
Oral Glucose Tolerance Test ◽  
Glucose Tolerance Test ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance ◽  
Test Completion

scholarly journals P032 Assessment of sputum glucose and sputum lactate using blood gas analyser during oral glucose tolerance test in cystic fibrosis

2019 ◽  
Vol 18 ◽  
pp. S65-S66
Author(s):  
B.U. Nielsen ◽  
M. Kolpen ◽  
P.Ø. Jensen ◽  
T. Pressler ◽  
D. Faurholt-Jepsen ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Glucose Tolerance ◽  
Oral Glucose Tolerance Test ◽  
Glucose Tolerance Test ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Blood Gas ◽  
Oral Glucose Tolerance

Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test?

2013 ◽  
Vol 38 (12) ◽  
pp. 1254-1259 ◽  
Author(s):  
Adèle Coriati ◽  
Belinda Elisha ◽  
Sandrine Virassamynaik ◽  
Maude Phaneuf ◽  
Sophie Ziai ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Glucose Tolerance ◽  
Oral Glucose Tolerance Test ◽  
Glucose Tolerance Test ◽  
Diagnostic Value ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance ◽  
Cross Sectional ◽  
Diagnostic Values

Adult patients with cystic fibrosis (APCF) are at high risk of developing impaired glucose tolerance (IGT) and CF-related diabetes (CFRD) and thus an annual screening with a 2-h oral glucose tolerance test (OGTT) is recommended. This population would greatly benefit from a simplified and harmless alternative to the standard OGTT. Thus, we aimed to compare the diagnostic values of HbA1c and glycemias at interval time points during the 2-h OGTT for IGT and CFRD detection in APCF. To do so, we conducted a cross-sectional analysis of 194 APCF with normal fasting plasma glucose values (≤7.0 mmol·L−1) who underwent a 2-h OGTT. Receivers operating characteristic area under the curves (ROC-AUC) were analyzed to assess the diagnostic value of HbA1c and intermediate OGTT glycemias using 2-h OGTT glycemia as reference. For both IGT and CFRD diagnoses, ROC-AUC values obtained from glycemia at 90 min were significantly higher than HbA1c and remaining intermediate glycemias (p < 0.001). The best 90-min OGTT cut-off values for these diagnoses were >9.3 mmol·L−1 (IGT) and ≥11.5 mmol·L−1 (CFRD). A 90-min OGTT glycemia might be a simplified alternative to 2-h OGTT glycemia for earlier glucose tolerance abnormalities diagnosis in APCF. This finding should be confirmed in other APCF cohorts and its predictive value should be established prospectively.

Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus

2013 ◽  
Vol 15 (4) ◽  
pp. 309-312 ◽  
Author(s):  
Renata Maria Noronha ◽  
Neiva Damaceno ◽  
Lúcia Harumi Muramatu ◽  
Osmar Monte ◽  
Luís Eduardo P Calliari
Keyword(s):  
Diabetes Mellitus ◽  
Cystic Fibrosis ◽  
Early Diagnosis ◽  
Glucose Tolerance ◽  
Oral Glucose Tolerance Test ◽  
Glucose Tolerance Test ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance
Sign in / Sign up

Export Citation Format

Share Document